EphB4 Tyrosine Kinase Stimulation Inhibits Growth of MDA-MB-231 Breast Cancer Cells in a Dose and Time Dependent Manner
Figure 2
Cell viability measured after 3 and 6 days of treatment with ephrinB2-Fc or Fc. (a) Cell viability did not change following 3 days of incubation compared to control (ANOVA; ). (b) Six days of treatment with ephrinB2-Fc, however, significantly decreased cell viability at concentrations of 3 μg/mL and 10 μg/mL but not 1 μg/mL. (ANOVA followed by Post-Hoc; , marked with asterisk). Error bars represent mean ± S.E.M of cell viability for three separate repeats.
